If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

16 Jan 2023 07:00

RNS Number : 7481M
Quixant PLC
16 January 2023
 

16 January 2023

Quixant plc

("Quixant" or the "Group")

Trading Update and Notice of Results

Record annual revenues

 

Quixant (AIM:QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, provides an update on trading for the financial year ended 31 December 2022 ("FY22").

 

Trading

 

The Board is pleased to confirm that, further to upgrading FY22 revenue expectations on 13 October 2022, positive trading across both the Gaming and Densitron businesses continued through the fourth quarter, reflecting the strong demand for our products. The Board expects to report full year revenues of $119.9m, 38% up year-on-year, the highest revenue performance in the Group's history, and slightly ahead of market expectations1. This is despite the backdrop of substantial supply and economic disruption. The Gaming business posted revenues of $74.1m, representing its best performance since 2018 and the Densitron business delivered $45.8m, beating the revenue record set in FY21 by 15%. 

 

The Group expects adjusted profit before tax to be slightly ahead of market expectations1. Whilst supply chain challenges persisted through the second half of FY22, a stabilisation in component pricing led to a partial recovery in gross margins towards historic levels.

 

FY22

FY21

Change

($m)

($m)

 

Group Revenue

119.9

87.1

38%

Gaming Revenue

74.1

 

47.3

 

57%

Densitron Revenue

45.8

 

39.8

 

15%

 

 

 

 

 

 

Financial position

 

Net cash at 31 December 2022 increased to $12.9m from $12.0m at 30 June 2022, driven by lower working capital requirements as the Group reduced the level of its strategic inventory holdings.

 

Outlook

 

The Group starts the new financial year with a strong order book, which provides good forward visibility supporting further revenue growth in FY23. Management continues to monitor macro-economic challenges, including recession, ongoing supply risks and inflationary pressures, but believes that the Group is well placed to continue to deliver good growth given its resilient end-markets and strategic positioning.

 

Notice of Results

The Group expects to report its full year results for 2022 on 21 March 2023.

Jon Jayal, Chief Executive Officer of Quixant plc, commented: "The Group has delivered an excellent year of growth, significantly ahead of initial expectations. Against a backdrop characterised by substantial supply and economic disruption, this performance is even more pleasing.

 

"This is testament to the strength of our customer relationships, quality of our people, resiliency in our management of supply chains and the value attributed to our innovative technology solutions. Driven by our growth strategy, we have exited the year with a more diversified product set, broader customer base and more robust platform from which to grow.

 

"As we start the new year, we remain cognisant of wider recessionary challenges however a robust order book supports further growth in FY23. We believe our business strategy positions us well for long-term diversified growth in the Group's revenue and profits."

 

1 The current range of forecasts for the year ended 31 December 2022 is revenue of between $115.3m and $115.1m with a consensus of $115.2m and adjusted profit before tax of $10.1m.

 

 

Quixant plc

Jon Jayal, Chief Executive Officer

Johan Olivier, Chief Financial Officer

 

Tel: +44 (0)1223 892 696

Nominated Adviser and Broker:

finnCap Ltd

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane / Charlotte Sutcliffe (ECM)

 

Tel: +44 (0) 20 7220 0500

Joint Broker:

Canaccord Genuity Limited

Simon Bridges / Andrew Potts

 

Tel: +44 (0) 20 7523 8000

Financial PR:

Alma PR

Hilary Buchanan / Kieran Breheny / Will Ellis Hancock

Tel: +44 (0)20 3405 0205

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming and broadcast industries. The Company is headquartered in Cambridge in the UK, with offices throughout Europe, North America and Asia. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support teams based in Italy and Slovenia. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGMMZKNGFZM
Date   Source Headline
10th Dec 20209:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSTrading Update
17th Nov 20205:52 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSExercise of Options
14th Oct 20206:15 pmRNSHolding(s) in Company
13th Oct 20207:00 amRNSDirector Shareholding
12th Oct 20203:17 pmRNSGrant of Options
7th Oct 20205:26 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSInterim Results
19th Aug 20207:00 amRNSAppointment of Interim CFO
10th Aug 20207:00 amRNSChanges to the Board of Directors
23rd Jul 20204:45 pmRNSHolding(s) in Company
23rd Jul 20204:05 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
3rd Jul 20205:57 pmRNSHolding(s) in Company
3rd Jul 20205:57 pmRNSHolding(s) in Company
19th May 20204:21 pmRNSResult of AGM
19th May 20207:00 amRNSTrading Update
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
29th Apr 20204:42 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSDesignate Director Shareholding
23rd Apr 20207:00 amRNSAppointment of Non-Executive Director
6th Apr 20207:00 amRNSAudited Final Results
3rd Apr 202012:23 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNS2019 Trading and COVID-19 update
27th Mar 20203:08 pmRNSTiming of Results
26th Mar 20204:50 pmRNSBoard Change
19th Mar 202012:50 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNotice of Results Update
12th Feb 20205:44 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
20th Dec 20195:50 pmRNSHolding(s) in Company
24th Oct 20194:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:05 pmRNSHolding(s) in Company
22nd Oct 20193:05 pmRNSHolding(s) in Company
14th Oct 20194:10 pmRNSDirector/PDMR Shareholding
7th Oct 20195:14 pmRNSDirector/PDMR Transfer Shareholding
27th Sep 20193:41 pmRNSHolding(s) in Company
23rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
19th Sep 20194:13 pmRNSDirector/PDMR Shareholding
18th Sep 20194:54 pmRNSDirector/PDMR Shareholding
17th Sep 20199:05 amRNSSecond Price Monitoring Extn
17th Sep 20199:00 amRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSTrading Update and Notice of Results
22nd Jul 201911:54 amRNSExercise of Options
4th Jul 20197:00 amRNSCompany Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.